State Offers Incentives to Get Docs Online

Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong

Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.

December 21st 2023

Exploration of Melanoma Incidence, Mortality Rates Urges Further Research

Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.

Listen

Skin Check for Melanoma | image credit: cunaplus - stock.adobe.com

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

A retrospective analysis out of Denmark could not find a causal relationship to explain trends in melanoma incidence and mortality rates, demonstrating the need for more research in this area.

November 30th 2023

Patients With DMD Receiving Eteplirsen Show Prolonged Survival, Study Finds

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

Duchenne medicial concept | Image credit: hafakot - stock.adobe.com

Galvanizing Community Oncology Through Advocacy, Empowerment, and Stewardship

The study provides evidence of survival benefits among patients with Duchenne muscular dystrophy (DMD) receiving eteplirsen compared with the natural history of the condition.

Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS

Coverage from the Community Oncology Alliance Community Oncology Conference, held April 4-5, 2024, in Orlando, Florida.

Related Content

Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong

December 21st 2023

Exploration of Melanoma Incidence, Mortality Rates Urges Further Research

Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.

Listen

Managed Care Cast Presents: Insights Into Precision Medicine in NSCLC

A retrospective analysis out of Denmark could not find a causal relationship to explain trends in melanoma incidence and mortality rates, demonstrating the need for more research in this area.

November 30th 2023

Patients With DMD Receiving Eteplirsen Show Prolonged Survival, Study Finds

In this podcast, a trio of experts discuss precision medicine in non–small cell lung cancer (NSCLC), current immunotherapies, and more.

Listen

Galvanizing Community Oncology Through Advocacy, Empowerment, and Stewardship

The study provides evidence of survival benefits among patients with Duchenne muscular dystrophy (DMD) receiving eteplirsen compared with the natural history of the condition.